Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 15;12(3):295-321.
doi: 10.14444/5036. eCollection 2018 Jun.

Review of Vertebral Augmentation: An Updated Meta-analysis of the Effectiveness

Affiliations

Review of Vertebral Augmentation: An Updated Meta-analysis of the Effectiveness

Douglas Beall et al. Int J Spine Surg. .

Abstract

Background: To update vertebral augmentation literature by comparing outcomes between vertebroplasty (VP), balloon kyphoplasty (BKP), vertebral augmentation with implant (VAI), and nonsurgical management (NSM) for treating vertebral compression fractures (VCFs).

Methods: A PubMed literature search was conducted with keywords kyphoplasty, vertebroplasty, vertebral body stent, and vertebral augmentation AND implant for English-language articles from February 1, 2011, to November 22, 2016. Among the results, 25 met the inclusion criteria for the meta-analysis. Inclusion criteria were prospective comparative studies for mid-/lower-thoracic and lumbar VCFs enrolling at least 20 patients. Exclusion criteria included studies that were single arm, systematic reviews and meta-analyses, traumatic nonosteoporotic or cancer-related fractures, lack of clinical outcomes, or non-Level I and non-Level II studies. Standardized mean difference between baseline and end point for each outcome was calculated, and treatment groups were pooled using random effects meta-analysis.

Results: Visual analog scale pain reduction for BKP and VP was -4.05 and -3.88, respectively. VP was better than but not significantly different from NSM (-2.66), yet BKP showed significant improvement from both NSM and VAI (-2.77). The Oswestry Disability Index reduction for BKP showed a significant improvement over VAI (P < .001). There was no significant difference in changes between BKP and VP for anterior (P = .226) and posterior (P = .293) vertebral height restoration. There was no significant difference in subsequent fractures following BKP (32.7%; 95% confidence interval [CI]: 8.8%-56.6%) or VP (28.3%; 95% CI: 7.0%-49.7%) compared with NSM (15.9%; 95% CI: 5.2%-26.6%).

Conclusions/level of evidence: Based on Level I and II studies, BKP had significantly better and VP tended to have better pain reduction compared with NSM. BKP tended to have better height restoration than VP. Additionally, BKP had significant improvements in pain reduction and disability score as compared with VAI.

Clinical relevance: This meta-analysis serves to further define and support the safety and efficacy of vertebral augmentation.

Keywords: balloon kyphoplasty; meta-analysis; vertebral augmentation; vertebral compression fractures; vertebroplasty.

PubMed Disclaimer

Conflict of interest statement

Disclosures and COI: This meta-analysis was conducted with funding from the International Society for the Advancement of Spine Surgery (ISASS); Benvenue Medical, Inc; DePuy Synthes Spine, a division of DePuy Orthopaedics, Inc; DFINE Inc; Globus Medical, Inc; Medtronic Sofamor Danek USA, Inc; and Stryker. Douglas Beall reports the following disclosures unrelated to the preparation of this manuscript: compensation, grants, and personal fees from Medtronic related to consultancy, research and teaching; grants from Benvenue, Alphatech Spine, Medical Metrics, Liventa, Vexim, and Mesoblast; consultancy fees from DEFINE and Osseon; other from Lilly, Smith & Nephew, Biomet, Vertiflex, Synthes, and Integral Spine Solutions. Morgan Lorio reports the following disclosures unrelated to the preparation of this manuscript: royalties from Choice Spine Thunderbolt, stock ownership in Orthogenerex, stock options with OrthoKinematics, intellectual property with Transformer Spine, investigator for Acadia Facet IDE Trial. B. Min Yun and Maria J. Runa are employees of Exponent, a scientific and engineering consulting firm. They have no other disclosures. Kevin Ong reports the following disclosures: employee and shareholder of Exponent, a scientific and engineering consulting firm. Exponent has been paid fees by entities in the biomedical arena for consulting services, including Zimmer Biomet, Stryker Orthopaedics, Joerns Healthcare, Ossur, DJO, Ethicon, Ferring Pharmaceuticals, Pacira Pharmaceuticals, Paradigm Spine, and Medtronic. Christopher B. Warner reports no disclosures.

Figures

Figure 1
Figure 1
Response ratios of standardized mean differences for visual analog scale pain scores comparing balloon kyphoplasty with vertebroplasty treatment.
Figure 2
Figure 2
Response ratios of standardized mean differences for visual analog scale pain scores comparing balloon kyphoplasty with vertebral augmentation with implants treatment.
Figure 3
Figure 3
Standardized mean differences of change from faseline for visual analog scale pain scores. Abbreviations: BKP, balloon kyphoplasty; VAI, vertebral augmentation with implants; NSM, nonsurgical management; VP, vertebroplasty.
Figure 4
Figure 4
Response ratios of standardized mean differences for Roland Morris Disability Questionnaire comparing nonsurgical management with vertebroplasty treatment.
Figure 5
Figure 5
Standardized mean differences of change from baseline for Roland Morris Disability Questionnaire. Abbreviations: BKP, balloon kyphoplasty; NSM, nonsurgical management; VP, vertebroplasty.
Figure 6
Figure 6
Response ratios of standardized mean differences for Oswestry Disability Index comparing balloon kyphoplasty with vertebroplasty treatment.
Figure 7
Figure 7
Response ratios of standardized mean differences for Oswestry Disability Index comparing balloon kyphoplasty with vertebral augmentation with implants treatment.
Figure 8
Figure 8
Standardized mean differences of change from baseline for Oswestry Disability Index. Abbreviations: BKP, balloon kyphoplasty; VAI, vertebral augmentation with implants; VP, vertebroplasty.
Figure 9
Figure 9
Response ratios of standardized mean differences for kyphotic angular correction comparing balloon kyphoplasty with vetebroplasty treatment.
Figure 10
Figure 10
Standardized mean differences of change from baseline for kyphotic angular correction. Negative values indicate reduction in kyphosis angle. Abbreviations: BKP, balloon kyphoplasty; VAI, vertebral augmentation with implants; NSM, nonsurgical management; VP, vertebroplasty.
Figure 11
Figure 11
Response ratios of standardized mean differences for anterior vertebral height comparing balloon kyphoplasty with vertebroplasty treatment.
Figure 12
Figure 12
Response ratios of standardized mean differences for posterior vertebral height comparing balloon kyphoplasty with vetebroplasty treatment.
Figure 13
Figure 13
Standardized mean differences of change from baseline for anterior vertebral height. Abbreviations: BKP, balloon kyphoplasty; VAI, vertebral augmentation with implants; VP, vertebroplasty.
Figure 14
Figure 14
Standardized mean differences of change from baseline for posterior vertebral height. Abbreviations: BKP, balloon kyphoplasty; VAI, vertebral augmentation with implants; VP, vertebroplasty.
Figure 15
Figure 15
Rate of subsequent fractures. Abbreviations: BKP, balloon kyphoplasty; NSM, nonsurgical management; VAI, vertebral augmentation with implants; VP, vertebroplasty.

Similar articles

Cited by

References

    1. Baaj AA, Downes K, Vaccaro AR, Uribe JS, Vale FL. Trends in the treatment of lumbar spine fractures in the United States: a socioeconomics perspective: clinical article. J Neurosurg Spine. 2011;15(4):367–370. doi: 10.3171/2011.5.SPINE10934. - DOI - PubMed
    1. Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine (Phila Pa 1976) 2000;25(8):923–928. - PubMed
    1. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535–1541. - PubMed
    1. Melton LJ., III Adverse outcomes of osteoporotic fractures in the general population. J Bone and Miner Res. 2003;18(6):1139–1141. doi: 10.1359/jbmr.2003.18.6.1139. - DOI - PubMed
    1. Cooper C, Atkinson EJ, O'Fallon WM, Melton JL., III Incidence of clinically diagnosed vertebral fractures: a population based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res. 1992;7(2):221–227. doi: 10.1002/jbmr.5650070214. - DOI - PubMed